How To Use HCPCS Code C9477

HCPCS code C9477 describes the injection of elotuzumab, with a dosage of 1 mg. This code is used to identify the specific procedure of administering elotuzumab through injection. In this article, we will explore the details of HCPCS code C9477, including its official description, procedure, when to use it, billing guidelines, historical information, Medicare and insurance coverage, and provide examples of when this code should be billed.

1. What is HCPCS C9477?

HCPCS code C9477 is a specific code used to identify the injection of elotuzumab, with a dosage of 1 mg. It is important for medical coders to accurately assign this code when reporting the administration of elotuzumab through injection.

2. Official Description

The official description of HCPCS code C9477 is “Injection, elotuzumab, 1 mg”. The short description for this code is “Enteral supp not otherwise c”.

3. Procedure

1. Prepare the elotuzumab injection according to the manufacturer’s instructions.
2. Verify the patient’s identity and confirm the correct dosage of 1 mg.
3. Select an appropriate injection site and clean the area with an antiseptic solution.
4. Administer the elotuzumab injection using a sterile syringe and needle.
5. Dispose of the used syringe and needle in a sharps container.
6. Document the administration of elotuzumab, including the dosage, injection site, and any adverse reactions or complications.

4. When to use HCPCS code C9477

HCPCS code C9477 should be used when reporting the injection of elotuzumab, with a dosage of 1 mg. It is important to ensure that the patient received the specific medication and dosage described in the code.

5. Billing Guidelines and Documentation Requirements

When billing for the administration of elotuzumab using HCPCS code C9477, healthcare providers should ensure that the following documentation is included:

• Medical record indicating the need for elotuzumab treatment
• Documentation of the dosage administered (1 mg)
• Injection site and method of administration
• Any adverse reactions or complications

Providers should follow the appropriate billing guidelines and submit the necessary documentation to ensure accurate and timely reimbursement.

6. Historical Information and Code Maintenance

HCPCS code C9477 was added to the Healthcare Common Procedure Coding System on January 1, 1985. It has a termination date of December 31, 2016. No maintenance actions have been taken for this code, as indicated by the action code N, which means no maintenance for this code. The code has been terminated and is no longer in use.

7. Medicare and Insurance Coverage

HCPCS code C9477 is subject to Medicare coverage and reimbursement. The pricing indicator code for this code is 57, which indicates that it is priced by other carriers. The multiple pricing indicator code is A, which means it is not applicable as HCPCS priced under one methodology. Providers should consult the Medicare Carriers Manual Reference Section Number 2130 for further guidance on coverage and reimbursement for this code.

8. Examples

Here are five examples of when HCPCS code C9477 should be billed:

1. A patient with multiple myeloma receives an injection of elotuzumab, 1 mg, as part of their treatment regimen.
2. A healthcare provider administers an elotuzumab injection, 1 mg, to a patient with relapsed/refractory multiple myeloma.
3. A patient undergoing a clinical trial receives an elotuzumab injection, 1 mg, as part of the study protocol.
4. An oncologist administers an elotuzumab injection, 1 mg, to a patient with newly diagnosed multiple myeloma.
5. A patient with smoldering multiple myeloma receives an elotuzumab injection, 1 mg, as part of their treatment plan.